Safe Orthopaedics appoints Pierre Dumouchel as interim chief executive officer

216

Safe Orthopaedics has appointed Pierre Dumouchel as its interim chief executive officer. Dumouchel co-founded the company, and previously held the position of chief operating officer.

Dumouchel will initiate a refocus of the company’s activities on France, Europe, and emerging markets, where it has perceived strong demand for its products.

Gérard Vaillant, chairman of Safe Orthopaedics’ Board of Directors, says, “Given his excellent knowledge of the company and his acclaimed leadership skills, it was an obvious decision to appoint Pierre pending the arrival of a new Chief Executive Officer. I have great faith in his ability to lead our new strategy and accelerate our strong growth in France, Europe and Emerging Markets, which still harbour largely under-exploited sales potential.”

Pierre Dumouchel adds, “My top priority will be to focus solely on France, Europe and Emerging Markets, to which I intend to reallocate the sales and marketing resources previously largely devoted to the United States. Our strong performance in these regions in spite of limited resources proves their very substantial potential. Despite lower selling prices than in the United States, these markets still have attractive margin potential given that the sales efforts required to attract and then maintain a solid customer base are considerably less extensive.”

Dumouchel has 11 years’ experience in spinal medical devices industry. He began his career in the automotive industry, before joining SpineVision in 2005 as Industrialisation project leader for the PediGuard. In 2008, he took over responsibility for SpineVision’s industrialisation department. In 2010, he co-founded Safe Orthopaedics and led the Industrialisation, Operations and Quality/Regulatory Affairs departments. Pierre holds a master’s degree in both advanced materials engineering and in management from the Conservatoire des Arts et Métiers and Institut Supérieur de Technologie et Management.

In addition to this appointment, Alain Coudray is joining the company’s Board of Directors as an independent director. He will draw on his international experience in medical devices in support of the refocused strategy.

Alain Coudray has over 20 years of experience in the medical devices industry. He has held various positions within Medtronic since June 2006, and become the vice president of Global Corporate Clinical Affairs in 2014.

Before joining Medtronic, Alain held the position of vice president of Central and Eastern Europe & Distributors for Guidant, based in Vienna, Austria. Alain is an active participant on the advisory board of MD Start, a MedTech incubator based in Paris, and was a Board Member of EUCOMED (European Medical Devices Industry association).